down arrow

Valiant Laborato

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0JWS01017
  • NSEID: VALIANTLAB
  • BSEID: 543998
INR
94.88
2.93 (3.19%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 15.7 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

93.0096.07

52 Week

75.86171.15
Valuation
Technical
Day's Volume

CASH

15.7 k (-90.51%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

74.94%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

  • Poor long term growth as Net Sales has grown by an annual rate of -21.00% and Operating profit at -151.01% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -6.14
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

Risky - Negative EBITDA

5

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 412 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

-4.31%

stock-summary
Price to Book

1.73

Revenue and Profits (1 Year):
Net Sales:
35 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-16.77%
0%
-16.77%
1 Year
-43.84%
0%
-43.84%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Valiant Laborato for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-21.00%
EBIT Growth (5y)
-151.01%
EBIT to Interest (avg)
-6.14
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.08
Tax Ratio
17.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
4.06%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
1.73
EV to EBIT
-26.16
EV to EBITDA
-30.35
EV to Capital Employed
1.74
EV to Sales
3.73
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.66%
ROE (Latest)
-4.31%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.0%)

Promoter with highest holding

Dhanvallabh Ventures Llp (46.84%)

Highest Public shareholder

Jainam Broking Limited (1.27%)

Individual Investors Holdings

17.55%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 64.01% vs 13.77% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 149.58% vs -829.41% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35.23",
          "val2": "21.48",
          "chgp": "64.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.62",
          "val2": "-6.74",
          "chgp": "109.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.06",
          "val2": "0.01",
          "chgp": "500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.35",
          "val2": "-4.74",
          "chgp": "149.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.76%",
          "val2": "-31.38%",
          "chgp": "33.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -63.62% vs -35.45% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -203.75% vs -55.42% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.36",
          "val2": "110.95",
          "chgp": "-63.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.14",
          "val2": "2.42",
          "chgp": "-477.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.06",
          "val2": "0.04",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.25",
          "val2": "5.06",
          "chgp": "-203.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-22.65%",
          "val2": "2.18%",
          "chgp": "-24.83%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -50.10% vs -37.57% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -285.90% vs -91.79% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "75.59",
          "val2": "151.47",
          "chgp": "-50.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.52",
          "val2": "-3.89",
          "chgp": "-119.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.12",
          "val2": "0.06",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.90",
          "val2": "1.56",
          "chgp": "-285.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-11.27%",
          "val2": "-2.57%",
          "chgp": "-8.70%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -45.48% vs 14.54% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -98.83% vs 5.45% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "182.05",
          "val2": "333.91",
          "chgp": "-45.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.41",
          "val2": "35.09",
          "chgp": "-123.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.08",
          "val2": "0.25",
          "chgp": "-68.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.34",
          "val2": "29.00",
          "chgp": "-98.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4.62%",
          "val2": "10.51%",
          "chgp": "-15.13%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
35.23
21.48
64.01%
Operating Profit (PBDIT) excl Other Income
0.62
-6.74
109.20%
Interest
0.06
0.01
500.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2.35
-4.74
149.58%
Operating Profit Margin (Excl OI)
1.76%
-31.38%
33.14%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 64.01% vs 13.77% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 149.58% vs -829.41% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
40.36
110.95
-63.62%
Operating Profit (PBDIT) excl Other Income
-9.14
2.42
-477.69%
Interest
0.06
0.04
50.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5.25
5.06
-203.75%
Operating Profit Margin (Excl OI)
-22.65%
2.18%
-24.83%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -63.62% vs -35.45% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -203.75% vs -55.42% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
75.59
151.47
-50.10%
Operating Profit (PBDIT) excl Other Income
-8.52
-3.89
-119.02%
Interest
0.12
0.06
100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.90
1.56
-285.90%
Operating Profit Margin (Excl OI)
-11.27%
-2.57%
-8.70%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -50.10% vs -37.57% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -285.90% vs -91.79% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
182.05
333.91
-45.48%
Operating Profit (PBDIT) excl Other Income
-8.41
35.09
-123.97%
Interest
0.08
0.25
-68.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.34
29.00
-98.83%
Operating Profit Margin (Excl OI)
-4.62%
10.51%
-15.13%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -45.48% vs 14.54% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -98.83% vs 5.45% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Valiant Laboratories Ltd stock-summary
stock-summary
Valiant Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of `M/s. Bharat Chemicals' through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name "Valiant Laboratories Limited" through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."